ChemoCentryx Marketed Drugs
Understand ChemoCentryx Inc’s commercialized product portfolio to stay one step ahead of the market.
A sample of ChemoCentryx Marketed Drugs data
| Drug Name | Generic Name | Brand Name | Company Name | Therapy Area | Indication | Development Stage | Drug Geography |
|---|---|---|---|---|---|---|---|
| Lorem | Lorem | Lorem | Lorem | Lorem | Lorem | Planned | Lorem |
| avacopan | avacopan | Tavneos | Vifor France SA | Immunology | Microscopic Polyangiitis (MPA) | Marketed | France |
| avacopan | avacopan | Tavneos | Vifor-Fresenius Medical Care Renal Pharma Ltd | Immunology | Granulomatosis with Polyangiitis (Wegener's Granulomatosis) | Marketed | Belgium |
| avacopan | avacopan | Tavneos | Vifor-Fresenius Medical Care Renal Pharma Ltd | Immunology | Granulomatosis with Polyangiitis (Wegener's Granulomatosis) | Marketed | Denmark |
Feature
Marketed Drugs is an integrated platform that provides interactive, comprehensive, and analytical competitive intelligence of Marketed Pharmaceutical Drug information.
Benefit
Marketed Drugs covers an extensive number of therapy areas and indications across 23 countries. Marketed Drug profiles provide a comprehensive breakdown of information spanning across Drug Details, Marketed Drug Overview (Lifecycle Management, Safety Details and Efficacy Details), Marketing Information (Regulatory Information), Clinical Trials, Sales and Consensus Forecast and Net Present Value.
Keep up-to-date on new Pipeline drug developments and market approvals. Competitive analysis of Marketed drugs.
Value
Marketed Drug data is used prominently to generate a range of premium analytical reports offering unique insight. Seamless integration makes in depth investigation of drugs extremely simple.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer